LU B 22 (Fenofibrate 145 mg)
Pill imprint LU B 22 has been identified as Fenofibrate 145 mg.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 145 mg
- Elliptical / Oval
- Prescription only
hypromellose 2910 (3 mPa.s)
sodium lauryl sulfate
More about fenofibrate
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.